Fate Therapeutics (FATE) – Major News
-
Fate Therapeutics (FATE) Tops Q4 EPS by 7c
-
Fate Therapeutics (FATE) Tops Q3 EPS by 10c
-
Fate Therapeutics (FATE) Tops Q2 EPS by 5c, misses on revenue
-
Fate Therapeutics (FATE) Tops Q1 EPS by 42c
-
Fate Therapeutics (FATE) Tops Q4 EPS by 28c
-
Fate Therapeutics (FATE) Tops Q3 EPS by 3c
-
Fate Therapeutics (FATE) Misses Q4 EPS by 5c
-
Fate Therapeutics (FATE) Misses Q2 EPS by 5c
-
Fate Therapeutics (FATE) Misses Q4 EPS by 22c
-
Fate Therapeutics (FATE) Misses Q2 EPS by 8c
-
Fate Therapeutics (FATE) Misses Q1 EPS by 5c
-
Fate Therapeutics (FATE) Tops Q4 EPS by 2c
-
Fate Therapeutics (FATE) Misses Q3 EPS by 2c
-
Fate Therapeutics (FATE) Misses Q1 EPS by 6c
-
Fate Therapeutics (FATE) Misses Q4 EPS by 1c, Revenues Miss
-
Fate Therapeutics (FATE) Misses Q3 EPS by 6c
-
Fate Therapeutics (FATE) Misses Q2 EPS by 6c
-
Fate Therapeutics (FATE) Misses Q1 EPS by 5c
-
Fate Therapeutics (FATE) Misses Q4 EPS by 5c
-
Fate Therapeutics (FATE) Misses Q3 EPS by 2c, Beats on Revenues
-
Fate Therapeutics (FATE) Tops Q2 EPS by 1c
-
Fate Therapeutics (FATE) Misses Q1 EPS by 4c, Beat on Revenues
-
Fate Therapeutics (FATE) Tops Q3 EPS by 2c
-
Fate Therapeutics (FATE) Tops Q2 EPS by 2c
-
Fate Therapeutics (FATE) Granted Fast Track Designation for ProTmune
-
Fate Therapeutics (FATE) Misses Q1 EPS by 4c
-
Fate Therapeutics (FATE) Tops Q4 EPS by 1c
-
Fate Therapeutics (FATE) Tops Q3 EPS by 6c
-
Fate Therapeutics (FATE) Announces Resignation of CEO Weyer; Successor Named
-
Fate Therapeutics (FATE) Tops Q2 EPS by 6c
-
Fate Therapeutics (FATE) Misses Q1 EPS by 1c
-
Fate Therapeutics (FATE) Tops Q4 EPS by 1c
-
Fate Therapeutics (FATE) Tops Q2 EPS by 7c
-
Fate Therapeutics (FATE) Misses Q1 EPS by 1c
-
Fate Therapeutics (FATE) Posts Q4 Loss of 29c/Share
-
Fate Therapeutics (FATE) IPO Opens Higher
Back to FATE Stock Lookup